| Financial Year |
March 31 2023 |
| Monetary Funds |
293,987,109.36 |
| Held-for-trading Financial Assets |
27,006,980.85 |
| Notes Receivable |
16,468,825.10 |
| Accounts Receivable |
378,875,268.83 |
| Advances to Suppliers |
19,678,070.06 |
| Other Receivables |
5,622,754.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
141,865,024.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
52,886,216.67 |
| Other Current Assets |
11,437,296.79 |
| Total Current Assets |
947,827,546.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
58,409,450.00 |
| Long-term Equity Investment |
196,283,999.92 |
| Investment Properties |
9,307,796.81 |
| Fixed Assetes |
268,321,389.51 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
230,667.23 |
| Intangible Assets |
23,470,671.66 |
| R&D expenses |
249,409.17 |
| Goodwill |
194,304,464.64 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
106,817,290.13 |
| Other Non-Current Assets |
7,210,434.39 |
| Sub-Total of Non-Current Assets |
897,761,067.53 |
| Total Assets |
1,845,588,614.15 |
| Short-Term Loans |
309,517,468.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
157,695,798.61 |
| Accounts Received In Advance |
601,479.03 |
| Employee Compensation Payable |
19,235,585.42 |
| Taxes Payable |
2,413,620.87 |
| Interest Payable |
-- |
| Dividend Payable |
14,000.00 |
| Other payables |
2,961,792.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,802,787.41 |
| Other Current Liabilities |
14,506,348.31 |
| Sub-Total of Current Liabilities |
512,766,012.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
9,276,795.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,023,519.81 |
| Deferred Income Tax Liabilities |
30,252,450.54 |
| Other Non-Current Liabilities |
1,022,254.14 |
| Sub-Total of Non-Current Liabilities |
51,344,131.75 |
| Total Liabilities |
564,110,143.90 |
| Paid-In Capital(Or Share Stock) |
590,908,629.00 |
| Capital Surplus |
1,312,067,865.55 |
| Surplus Reserve |
41,848,815.74 |
| LESS:Treasury Stock |
22,122,915.66 |
| Undistributed Profits |
-695,742,183.31 |
| Minority Stockholder's Interest |
18,350,100.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,263,128,369.89 |
| Owner's Equity（Stockholder's Equity） |
1,281,478,470.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,845,588,614.15 |
